Table 3 Raw and adjusted macular VD differences across diagnostic groups.
Group (n) | Mean | SD | Meanaa | SEMaa |
|---|---|---|---|---|
VD nasal | ||||
CU (n = 128) | 49.18 | 5.52 | 48.94 | 0.68 |
MCI-AD (n = 120) | 49.81 | 6.14 | 49.81 | 0.57 |
MCI-Va (n = 111) | 48.95 | 7.16 | 49.01 | 0.60 |
ADD (n = 257) | 49.17 | 5.87 | 49.21 | 0.41 |
VaD (n = 56) | 49.51 | 6.67 | 49.78 | 0.87 |
VD superior | ||||
CU (n = 128) | 51.10 | 5.04 | 50.52 | 0.76 |
MCI-AD (n = 120) | 51.18 | 6.09 | 51.16 | 0.64 |
MCI-Va (n = 111) | 50.21 | 6.93 | 50.30 | 0.67 |
ADD (n = 257) | 50.88 | 7.63 | 51.09 | 0.46 |
VaD (n = 56) | 51.76 | 8.32 | 51.92 | 0.97 |
VD temporal | ||||
CU (n = 128) | 47.58 | 4.17 | 47.27 | 0.58 |
MCI-AD (n = 120) | 48.97 | 4.91 | 49.05 | 0.48 |
MCI-Va (n = 111) | 47.71 | 4.98 | 47.78 | 0.51 |
ADD (n = 257) | 48.42 | 5.53 | 48.50 | 0.35 |
VaD (n = 56) | 48.55 | 6.80 | 48.56 | 0.73 |
VD inferior | ||||
CU (n = 128) | 51.20 | 6.39 | 51.27 | 0.80 |
MCI-AD (n = 120) | 49.41 | 6.95 | 49.68 | 0.67 |
MCI-Va (n = 111) | 48.86 | 6.57 | 48.70 | 0.71 |
ADD (n = 257) | 50.25 | 8.10 | 50.23 | 0.49 |
VaD (n = 56) | 51.69 | 7.60 | 51.37 | 1.02 |